Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 653 (ZNF653) is a human transcriptional repressor and coregulator containing five C2H2-type zinc finger domains. It primarily acts by repressing the transcriptional activity of several nuclear receptors, including NR5A1 (SF-1), PPARG, NR1H3 (LXRα), NR4A2 (NUR77), ESR1 (ERα), and NR3C1 (glucocorticoid receptor). ZNF653 interacts directly with the ligand-binding domains of these receptors, modulating their activity in gene regulation. Although it belongs to the largest family of putative transcription factors in humans, and serves as a general regulatory cofactor for several nuclear receptor pathways, its specific biological and disease implications are not well characterized. It is primarily classified as a poly-zinc finger transcription factor and does not currently have a recognized role as a therapeutic target. If further disease-specific roles or therapeutic relevance are discovered in future research, additional entries may become relevant. Currently, ZNF653 functions mainly as a transcriptional regulator, not as a classic drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 653 (ZNF653).